Simon Carding
Programme Leader
Research Area: Integrated Biology of GI Tract
Contact Details:
Institute of Food Research,
Norwich Research Park,
Colney, Norwich,
NR4 7UA
UK
simon.carding@ifr.ac.uk
Recent Publications
Marsh L., Coletta P. L., Hull M. A., Selby P. J., Carding S. R. (2012)
Altered intestinal epithelium-associated lymphocyte repertoires and function in ApcMin/+ mice
International Journal of Oncology 40 (1) 243-250
Altered intestinal epithelium-associated lymphocyte repertoires and function in ApcMin/+ mice
International Journal of Oncology 40 (1) 243-250
Hamady Z. R., Scott N., Farrar M. D., Dilger P. G., Thorpe R., Lodge J. P. A., Holland K. T., Whitehead T., Carding S. R. (2011)
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-b1 under the control of dietary xylan
Inflammatory Bowel Disease 17 (9) 1925-1935
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-b1 under the control of dietary xylan
Inflammatory Bowel Disease 17 (9) 1925-1935
Mizushima N., Stappenbeck T. S., Rioux J. D., Mizoguchi A., Saitoh T., Huett A., Darfeuille-Michaud A., Carding S. R., Wileman T., Akira S., Parkes M., Xavier R. J. (2011)
Crohns disease: A current perspective on genetics, autophagy and immunity
Autophagy 7 (4) 355-374
Crohns disease: A current perspective on genetics, autophagy and immunity
Autophagy 7 (4) 355-374
Meader E., Mayer M. J., Gasson M. J., Steverding D., Carding S. R., Narbad A. (2010)
Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system
Anaerobe 16 (6) 549-554
Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system
Anaerobe 16 (6) 549-554
Fax: +44(0)1603 507723 
